Skip to main content

Walleye Capital LLC

Position in WGS — GeneDx Holdings Corp.

CIK 1758720 NEW YORK, NY

Position in WGS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$4,661,335
+$2,738,138 QoQ
Shares Held
67,900
+359.2% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#58
of 222 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Dec 31, 2025
CallValue
$2,900,338
CallShares
22,300
PutValue
$975,450
PutShares
7,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $25,239,598 across 16 Diagnostics & Research names. WGS ranks #2 (18.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 WGS
GeneDx Holdings Corp.
This page
67,900 $4,661,335

All Filings in WGS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,661,335 67,900
2025-12-31 $2,900,338 22,300
2025-12-31 $1,923,197 14,787
2025-12-31 $975,450 7,500
2025-09-30 $527,926 4,900
2025-09-30 $844,250 7,836
2025-09-30 $527,926 4,900
2025-06-30 $360,009 3,900
2025-06-30 $18,462 200
2025-03-31 $239,125 2,700
2025-03-31 $230,269 2,600
2024-12-31 $292,068 3,800
2022-06-30 $13,073 10,376
2020-12-31 CMLF 21,900